| HOME >> BIOLOGY >> TECHNOLOGY |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(unaudited)
For the three months
ended March 31,
2008 2007
Revenue $11,717,045 $7,233,768
Cost of revenue 5,909,768 3,934,849
Gross profit 5,807,277 3,298,919
Operating expenses:
Selling expenses 337,792 147,883
General and administrative 815,793 1,306,086
Total operating expenses 1,153,585 1,453,969
Income from operations 4,653,692 1,844,950
Non-operating income (expenses):
Interest income
-- 13,775
Interest expense (45,273) (56,899)
Other income -- 572,213
Total non-operating income (expense) (45,273) 529,089
Income before taxes 4,608,419 2,374,039
Income tax expense 417,878 --
Net income $4,190,541 $2,374,039
Comprehensive income - foreign currency
translation adjustments 1,745,242 216,416
Comprehensive income $5,935,783 $2,590,455
Basic and Diluted Earnings Per Share $0.11 $0.07
Basic and Diluted Weighted Average
Shares Outstanding 37,278,938 36,337,958
'/>"/>| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |